Quantum Helium Limited (QHE) provided shareholders with a review of the key milestones achieved over the past twelve months ahead of the Company’s Extraordinary General Meeting (“EGM”), which is scheduled to be held next week on 1 July.
The past year has seen the transformation of the Company from a diversified oil and gas business into a focused helium and energy company centred on two independently assessed helium and energy projects in Colorado – Sagebrush and Coyote Wash – representing one of the largest independently assessed helium resource positions on the London market.
Comment: QHE finesses yesterday’s research note from our dear friends at Oak Securities, with more reassurance regarding its helium portfolio. Perhaps it will be the first of the growing number of such plays on the London market to actually produce the stuff?
Avacta Therapeutics (AVCT), a clinical stage biopharmaceutical company developing pre|CISION®, a tumor-activated oncology delivery platform, today announced that it has agreed the pivotal trial design for faridoxorubicin (AVA6000, pre|CISION-enabled doxorubicin) with the U.S. Food and Drug Administration (FDA) for a potential full regulatory approval. AVCT also nnounces platform-validating data with faridoxorubicin (AVA6000, pre|CISION®-enabled doxorubicin) in patients with salivary gland cancer (SGC) where robust tumor responses are observed with low expression of fibroblast activation protein (FAP) and the persistence of FAP expression despite tumor response.
Comment: It has been a little on the quiet side as far as newsflow from AVCT, so a double helping from the retail investor’s favourite / stock market darling, should help to re-instate the 25% rally we have seen in the shares since the start of the year. One love’s a good tumor response early in the morning.
On 10 June 2026, Mercantile Ports & Logistics Limited (MPL) announced that its application challenging the decision of the Committee of Creditors (“CoC”) which rejected the promoters’ Section 12A proposal and approved the resolution plan relating to Karanja Terminal & Logistics Private Limited (“KTPL”) could not be heard on 8 June 2026. The Company has now been informed that the matter is scheduled to be heard before the National Company Law Tribunal (“NCLT”), Mumbai Bench, on 1 July 2026.
Comment: Although up overall since the beginning of the year, shares of MPL continue to move around like a heart trace monitor, and perhaps this volatility will only start to fade one D-Day on July 1 is finally out of the way.
Caspian Sunrise PLC (CASP) updated shareholders with encouraging progress at the Yelemes Deep structure on the BNG Contract Area, which has resulted in an accelerated and expanded drilling programme and also with news of a new shallow well to be drilled on BNG’s Airshagyl structure.
Comment: We should be grateful that today’s news has allowed shares of CASP to finally stage a meaningful rebound. However, it is clear that a fussy market will only be satisfied once we get a solid drilling result.
ImmuPharma plc (IMM), the specialist drug discovery and development company, is pleased to announce that, following a competitive tender process, it has appointed Bachem AG as manufacturing partner for the active pharmaceutical ingredient (“API”) for its Kapiglucagon program. Bachem is a leading global peptide and oligonucleotide development and manufacturing partner, supporting pharmaceutical and biotechnology companies from early-stage development through to commercial supply.
Comment: The share price of IMM continues to disappoint, something which it could be argued is at odds with the newsflow and the real, positive prospects for the company. At the moment it is hard to envisage what could be the lightnight rod for a decent rally.
BATM (BVC), a global provider of advanced network infrastructure and cybersecurity technologies, is pleased to announce that it has secured a new customer in the US that is a leading broadband communications provider serving more than 1.1 million residential and business customers across 24 states. The initial order for one of BATM’s new Carrier Ethernet products is worth $500k and is expected to be delivered in the current financial year.
Comment: London listed companies who gain traction in the US should really get rather more credit than they normally do, especially when there are decent dollar earning contracts being won. In the case of BVC have stabilised of late, but are still well off where they were even last autumn.
Aptamer Group plc (APTA), the developer of next-generation synthetic binders for the life sciences industry, announced an update on the delivery of strategic initiatives across its platform technology and therapeutic development programmes, supported by the April 2026 fundraise. The Group is making simultaneous progress across its AI platform, platform automation, and therapeutic pipeline, demonstrating strong operational momentum across multiple pillars of the business.
Comment: The climbdown for the shares since September has been quite painful, and even with the fundraise out of the way the market has been forced to adopt a suck it and see approach to hoping that the company can deliver progress which delivers revenue rather than just “operational momentum.”
easyJet plc (EZJ) noted that on 23 June 2026, it received a further indicative and conditional proposal from Castlelake, L.P. to acquire the entire issued and to be issued ordinary share capital of easyJet not already held by Castlelake for £6.50 per share in cash, including a partial alternative for easyJet shareholders to elect for unlisted, non-transferrable, non-voting shares in a vehicle within Castlelake’s proposed structure. Having carefully reviewed it with its advisers, the Board of easyJet continues to regard the Fourth Proposal as substantially undervaluing the Company and its prospects and continuing to give rise to significant questions of deliverability. Accordingly, the Board of easyJet has unanimously rejected the Fourth Proposal.
Comment: EZJ continues to protest to much as far as the offer from Castlelake, but at least the share price has bounced and continues to bounce from the lowly levels of the year towards 340p. While it may be able to wriggle out of its bidder’s clutches, most near term players in the (front run) takeover situation would surely be happy with anything over 600p.
Oracle Power PLC (ORCP), an international project developer, is pleased to announce its Final Results for the year ended 31 December 2025 and that the 2026 Annual General Meeting of the Company is to be held at the offices of Charles Russell Speechlys LLP, 5 Fleet Place, London EC4M 7RD on 24 July 2026 at 11.00 a.m.
Comment: Having opened up the pdf on ORCP’s results it can be seen that last year it lost £500,000 versus around £700k. Given how active the company has been especially with regard to its Northern Zone activities, one might consider the financial performance as being something of a result, all the more if the project actually delivers.
Tower Resources plc (TRP), the AIM-listed oil and gas company focused on Africa, is delighted to announce that it has received a formal letter of approval from the Namibian Ministry of Industries, Mines and Energy for the farm-out of the PEL96 license, offshore Namibia, to Prime Global Energies Limited. This represents the finalisation of the only outstanding condition precedent under the PEL96 farm-out contract, announced on 10 January 2025. The Company will now send out a notice of completion to Prime, and a draft deed of assignment, novation and amendment to MIME and Tower’s partners, with completion expected to follow shortly.
Comment: One notes that after a long, long gestation period, TRP is actually making a genuine advance. Perhaps the saving grace here is that even though the shares are down by a third year to date, the company’s market cap is still £7m, so it is not a complete minnow and could build from here.
Zinc Media Group plc (ZIN), the award-winning television, brand and audio production group, is pleased to announce that WHAM! 10 Days in China, a feature documentary produced by Supercollider, will receive a worldwide theatrical release through Sony Music Vision and leading event-cinema distributor Trafalgar Releasing, followed by an exclusive UK broadcast on the BBC. The 90-minute film, directed by Mike Christie, tells the story of WHAM!’s landmark 1985 concerts in Beijing and Guangzhou – the first by a Western pop group in China.
Comment: Despite the odd careless whisper, I’m your man as far as covering the ZIN story. Even as recently as last Christmas one would never have imagined that ZIN would be making such regular progress on the documentary making front, and that finally the stock market is starting to appreciate the value creation in share price terms. The shares are up over 30% in the past month, certainly an opportunity to go and celebrate at Club Tropicana. Apparently drinks there are free.
Disclaimer & Declaration of Interest:
The information, investment views, and recommendations in this Zaks Traders Cafe interview are provided for general information purposes only. Nothing in this interview should be construed as a promotion or solicitation to buy or sell any financial product relating to any companies under discussion or referred to or to engage in or refrain from doing so or engage in any other transaction. Any opinions or comments are made to the best of the knowledge and belief of the commentator but no responsibility is accepted for actions based on such opinions or comments. The commentators may or may not hold investments in the companies under discussion.
